These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16635613)

  • 61. Nesiritide - not verified.
    Topol EJ
    N Engl J Med; 2005 Jul; 353(2):113-6. PubMed ID: 16014879
    [No Abstract]   [Full Text] [Related]  

  • 62. Impact of nesiritide on renal function and mortality in patients suffering from heart failure.
    Dontas ID; Xanthos T; Dontas I; Lelovas P; Papadimitriou L
    Cardiovasc Drugs Ther; 2009 Jun; 23(3):221-33. PubMed ID: 19252976
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Short and long-term mortality with nesiritide.
    Arora RR; Venkatesh PK; Molnar J
    Am Heart J; 2006 Dec; 152(6):1084-90. PubMed ID: 17161057
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nesiritide--not verified.
    April PA
    N Engl J Med; 2005 Oct; 353(14):1525-7; author reply 1525-7. PubMed ID: 16211707
    [No Abstract]   [Full Text] [Related]  

  • 65. Efficacy and safety of a modified dosage regimen of nesiritide in patients older than 75 years with acute heart failure.
    Fu S; Yi S; Zhu B; Wang L; Wang H; Bai Y; Ye P; Luo L
    Aging Clin Exp Res; 2012 Oct; 24(5):524-9. PubMed ID: 22395196
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Natriuretic and neurohormonal responses to nesiritide, furosemide, and combined nesiritide and furosemide in patients with stable systolic dysfunction.
    Sica D; Oren RM; Gottwald MD; Mills RM;
    Clin Cardiol; 2010 Jun; 33(6):330-6. PubMed ID: 20556802
    [TBL] [Abstract][Full Text] [Related]  

  • 67. BNP-mediated vasodilatation for dialysis-dependent patient with acute heart failure syndrome in the emergency department.
    Chandra A; Otero R; Freeman D; Cairns CB
    Ren Fail; 2008; 30(1):45-50. PubMed ID: 18197542
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.
    Mills RM; LeJemtel TH; Horton DP; Liang C; Lang R; Silver MA; Lui C; Chatterjee K
    J Am Coll Cardiol; 1999 Jul; 34(1):155-62. PubMed ID: 10400005
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.
    Munger MA; Ng TM; Van Tassell BW
    Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin].
    Xie CL; Meng SR; Wang W; Chen SM; Li P; Feng XG
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):839-42. PubMed ID: 18504215
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Nesiritide, a novel treatment for heart failure].
    Francisco-Méndez G
    Rev Med Inst Mex Seguro Soc; 2007; 45(3):281-9. PubMed ID: 17692167
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery.
    Ejaz AA; Martin TD; Johnson RJ; Winterstein AG; Klodell CT; Hess PJ; Ali AK; Whidden EM; Staples NL; Alexander JA; House-Fancher MA; Beaver TM
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):959-64. PubMed ID: 19660420
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment with B-type natriuretic peptide for chronic decompensated heart failure: insights learned from the follow-up serial infusion of nesiritide (FUSION) trial.
    Yancy CW
    Heart Fail Rev; 2004 Jul; 9(3):209-16. PubMed ID: 15809819
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nesiritide Therapy Is Associated With Better Clinical Outcomes Than Dobutamine Therapy in Heart Failure.
    Kong LG; Wang CL; Zhao D; Wang B
    Am J Ther; 2017; 24(2):e181-e188. PubMed ID: 26164026
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of nesiritide to treat acute decompensated heart failure.
    Hachey DM; Smith T
    Crit Care Nurse; 2003 Feb; 23(1):53-5. PubMed ID: 12640959
    [No Abstract]   [Full Text] [Related]  

  • 76. Nesiritide for acute decompensated heart failure.
    Alhosaini H
    Am Fam Physician; 2006 Oct; 74(8):1279; author reply 1279-80. PubMed ID: 17087421
    [No Abstract]   [Full Text] [Related]  

  • 77. Is there a use for nesiritide in pediatric patients?
    Schamberger MS
    J Intensive Care Med; 2004; 19(3):171-3. PubMed ID: 15154998
    [No Abstract]   [Full Text] [Related]  

  • 78. Comparison of ultrafiltration, nesiritide, and usual care in acute decompensated heart failure.
    Bartone C; Saghir S; Menon SG; Brosmer J; Kereiakes DJ; Mazur W; Chung ES
    Congest Heart Fail; 2008; 14(6):298-301. PubMed ID: 19076851
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.
    Riter HG; Redfield MM; Burnett JC; Chen HH
    J Am Coll Cardiol; 2006 Jun; 47(11):2334-5. PubMed ID: 16750705
    [No Abstract]   [Full Text] [Related]  

  • 80. Nesiritide as an adjunctive therapy in adult patients with heart failure undergoing high-risk cardiac surgery.
    Samuels LE; Holmes EC; Lee L
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):627-9. PubMed ID: 15457170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.